Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer

Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer

BackgroundThe aim of this article was to establish the clinical prognostic models and identify the predictive radiation dosimetric parameters for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer.MethodsIn this retrospective cohort study, patients with rectal adenocarcinoma unde...

Full description

Bibliographic Details
Main Authors:	Yue Teng, Dapeng Ma, Yan Yan, Jianhao Geng, Zhiyan Liu, Xianggao Zhu, Shuai Li, Yangzi Zhang, Hongzhi Wang, Yong Cai, Haizhen Yue, Yongheng Li, Weihu Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Oncology
Subjects:	rectal cancer thrombocytopenia concurrent chemoradiotherapy risk factors clinical predictors radiation dosimetric parameters
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1289824/full

Similar Items

Radiotherapy dose–volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinoma
by: Donghyun Kim, et al.
Published: (2021-09-01)

Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
by: Po-Jung Chen, et al.
Published: (2021-07-01)

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer
by: Yi-Jung Huang, et al.
Published: (2022-08-01)

Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
by: Hiroshi Mayahara, et al.
Published: (2022-01-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

High Mean Corpuscular Volume as a Predictor of Poor Overall Survival in Patients with Esophageal Cancer Receiving Concurrent Chemoradiotherapy
by: Li K, et al.
Published: (2020-08-01)

Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy
by: Soo-Yoon Sung, et al.
Published: (2022-08-01)

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
by: Raminta Stuopelytė, et al.
Published: (2023-04-01)

Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
by: Yuanxiu Yin, et al.
Published: (2022-07-01)

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Neoadjuvant chemoradiotherapy induced lymphopenia in gastric cancer and associations with spleen dosimetry and survival outcomes
by: Ji-jin Wang, et al.
Published: (2023-05-01)

The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin
by: Igor Sirák, et al.
Published: (2008-01-01)

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Kailin Wang, et al.
Published: (2019-05-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study
by: Jeong Yun Jang, et al.
Published: (2021-12-01)

Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
by: Xinmao Song, et al.
Published: (2019-07-01)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
by: Haonan Liu, et al.
Published: (2022-12-01)

LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer
by: Zhang Y, et al.
Published: (2021-11-01)

MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study
by: Yirong Xiang, et al.
Published: (2023-01-01)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
by: Akihiko Wakayama, et al.
Published: (2017-08-01)

Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy
by: Xin Li, et al.
Published: (2023-10-01)

Efficacy of modified neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A single institution experience in Taiwan
by: Yi-Ying Wu, et al.
Published: (2014-01-01)

Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction
by: Mladen Marinkovic, et al.
Published: (2024-01-01)

Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial
by: Velenik Vaneja, et al.
Published: (2020-08-01)

Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy
by: Yi Sun, et al.
Published: (2023-03-01)

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy
by: Fraunholz Ingeborg, et al.
Published: (2012-06-01)

The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis
by: Bi-Cheng Wang, et al.
Published: (2020-05-01)

Outcome of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in non-metastatic locally advanced non-small cell lung cancer – A prospective and randomized study
by: Subir Pal, et al.
Published: (2023-01-01)

Role of adjuvant chemotherapy in patients with rectal cancer after preoperative chemoradiotherapy: results of a retrospective study
by: M. Yu. Fedyanin, et al.
Published: (2018-07-01)

Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study
by: Xia WX, et al.
Published: (2019-11-01)

Clinical Outcomes of Patients With Locally Advanced Rectal Cancer With Persistent Circumferential Resection Margin Invasion After Preoperative Chemoradiotherapy
by: Chang Hyun Kim, et al.
Published: (2019-04-01)

Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2021-03-01)

Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non‐small cell lung carcinoma
by: Nobuyuki Hirama, et al.
Published: (2023-09-01)

Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
by: Ji‐An Liang, et al.
Published: (2020-09-01)

Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study
by: Xiaoxue Huang, et al.
Published: (2023-03-01)

Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
by: Hai Liu, et al.
Published: (2024-01-01)

Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
by: Yuki Nakamura, et al.
Published: (2018-09-01)

The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma
by: Liang ZG, et al.
Published: (2020-02-01)

C-Reactive Protein as Predictive Biomarker for Response to Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Retrospective Study
by: Fátima Aires, et al.
Published: (2022-01-01)